AtheroNova ($AHRO) C.E.O. Thomas W. Gardner on AtheroNova potential

AtheroNova ($AHRO) C.E.O. Thomas W. Gardner on AtheroNova potential

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.  The Company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion dollar prescription drug market: cardiovascular disease and stroke prevention.

In this film, AtheroNova's C.E.O. Thomas W. Gardner talks about the founding of and the potential for AtheroNova: http://www.filmannex.com/